Reader’s Guide Mefluidide

CRM: Wilhelmena Livingston

EPA/OPPTS/OPP/SRRD

Reader’s Guide to Mefluidide Docket # EPA-HQ-OPP-2007-0431

Publication Date: June 20, 2007

	EPA has created this document to provide an organizational structure to
the Mefluidide Docket for Public Comments.  The docket index groups
related documents.  The first group contains the Federal Register and
Docket Organizational Documents; the second group contains the Human
Health Risk Assessment for Phase 3 Public Comments, the third group
contains the Environmental Risk Assessment documents for Phase 3 Public
Comments.  The Agency is providing the “Reader’s Guide” to allow
the reader to more easily access and navigate the various items
contained in the Mefluidide docket.  

Federal Register and Docket Organizational Documents:

Docket Item 1.	Federal Register Notice:  Mefluidide Risk Assessments;
Notice of 				Availability (Phase 3 of 4-Phase Process)

This notice announces that the risk assessments are available for the
public review and comment.

Docket Item 2.	Reader’s Guide to the Mefluidide Docket #
EPA-HQ-OPP-2007-				0431

The reader’s guide is designed to give a brief description of all the
mefluidide documents in the mefluidide docket.

Use Profile:

Docket Item 3.	Mefluidide Use Closure Memo

This document clarifies mefludide uses for the Reregistration
Eligibility Decision (RED) risk assessment.

Attachment to the Use Closure Memo:

Docket Item 4.	Table A3. Non-Food/Non-Feed Use Patterns Summary for 				
Mefluidide (Case 2370)

Docket Item 5.	Table A3. Non-Food-Feed Use Patterns Summary for
Mefluidide, 				diethanolamine salt (CASE 2370)

Docket Item 6.	Table A3. Non-Food/Non-Feed Use Patterns Summary for 				
Potassium mefluidide (CASE 2370)

Docket Item 7.	Table A3. Non-Food/Non-Feed Use Patterns Summary for 				
Mefluidide, diethanolamine salt by Acid Equivalent 					(CASE 2370)

Human Health Risk Assessment Documents for Phase 3 Public Comments:

Docket Item 8.	Mefluidide; Diethanolamine Mefluidide, and Potassium 				
Mefluidide- Phase 2, (30-Day Error only Correction), HED 					Chapter of
the Re-registration Eligibility Decision Document 				(RED).

			(May 30, 2007)

This document describes all the human health risk from the use of
mefluidide.

Docket Item 9.	Mefluidide - Toxicology Section for the Reregistration
Eligibility 				Decision Document (RED)

			(January 31, 2007)

This document reports the review of the Hazard Identification Assessment
Risk Committee with regards to the acute and chronic reference doses and
the toxicological endpoint selection for use as appropriate in the
occupational/residential exposure risk assessment. 

Docket Item 10.	Mefluidide – Occupational and Residential Exposure and
Risk 				Assessment for the Reregistration Eligibility Decision (RED)

			(February 28, 2007)

This document describes the occupational and residential exposure and
risk assessment for the Mefluidide RED.

Appendices for the Occupational and Residential Exposure and Risk
Assessment for the Reregistration Eligibility Decision (RED)

Docket Item 11.	Appendix A 1-3 Standard Formulas Used for Calculating 		
		Occupational and Residential Exposures to Mefluidide; 					Ocupational
Handler Exposure Data and;Risk Calculations for 				Mefluidide;
Residential Handler Exposure Data and Risk 					Calculations for
Mefluidide

Docket Item 12.	Appendix B – Mefluidide Occupational Handler Risks

Docket Item 13.	Appendix C – Residential Handler Risks

Docket Item 14.	Appendix D – Residential Turf Post Application Risk 		
		Assessment for Melfuidide

		

Docket Item 15.	Mefluidide Incident Report

			(July 25, 2006)

This document reports the poisoning incident data on the active
ingredient mefluidide.

Environmental Fate and Effects Documents Phase 3 Public Comments:

Docket Item 16.	Error Corrections First Phase for Reregistration of
Mefluidide 				acid, Mefluidide-DEA and Mefluidide-K

			(June 7, 2007)

This is the transmittal memo for the Environmental Fate and Effects
Division (EFED) revised environmental risk assessment for Phase 1 error
corrections only.

Docket Item 17.	Re-registration Eligibility Document Environmental Fate
and 				Effects Science Chapter

			(June 7, 2007)

This document describes the ecological effects of mefluidide.

Docket Item 18.	Drinking Water Assessment for N-[2,4-dimethyl-5-					
[[(trifluoromethyl)sulfonyl]amino]phenyl]acetamide 					(Mefluidide), 
N-{2,4-dimentyl-5-							
]]trifluoromethyl)sulfonyl]amino]phenyl’acetamide 						monopotassium
salt (Potassium Mefluidide), and N-[2,4-					dimethyl-		

			5[[(trifluoromethyl)salfonyl]amino]phenyl]actamide 

			Compound with 2,2-iminobsi[ethanol] (1:1)

			(May 9, 2007)	

This document represents the Agency’s current drinking water
assessment for Mefluidide.

